Paxlovid for the treatment of COVID-19: Place in Therapy, Safety Considerations & Management of Drug Interactions
This webinar was recorded on 12th of April 2022
Presented by
Muriel Pate, Medication Safety Specialist Pharmacist, HSE Quality & Patient Safety Directorate
Marie Philbin, Chief I Antimicrobial Pharmacist, National Antimicrobial Resistance & Infection Control Team, HSE
This webinar was recorded on 12th of April 2022
Presented by
Muriel Pate, Medication Safety Specialist Pharmacist, HSE Quality & Patient Safety Directorate
Marie Philbin, Chief I Antimicrobial Pharmacist, National Antimicrobial Resistance & Infection Control Team, HSE
- Category
- Health
Be the first to comment